Canada markets close in 1 hour 9 minutes

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.8000-0.1700 (-4.28%)
As of 02:47PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 171.08M
Enterprise Value 209.57M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.49
Price/Book (mrq)2.34
Enterprise Value/Revenue 1.87
Enterprise Value/EBITDA 26.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3-18.81%
S&P500 52-Week Change 321.23%
52 Week High 36.2900
52 Week Low 33.7900
50-Day Moving Average 34.3568
200-Day Moving Average 34.5197

Share Statistics

Avg Vol (3 month) 386.75k
Avg Vol (10 day) 3105.41k
Shares Outstanding 543.42M
Implied Shares Outstanding 643.42M
Float 835.1M
% Held by Insiders 17.28%
% Held by Institutions 178.38%
Shares Short (Mar 28, 2024) 4636.65k
Short Ratio (Mar 28, 2024) 47.02
Short % of Float (Mar 28, 2024) 41.58%
Short % of Shares Outstanding (Mar 28, 2024) 41.47%
Shares Short (prior month Feb 29, 2024) 4712.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21319:1000
Last Split Date 3Nov 04, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -3.04%
Operating Margin (ttm)3.14%

Management Effectiveness

Return on Assets (ttm)1.10%
Return on Equity (ttm)-4.70%

Income Statement

Revenue (ttm)112.25M
Revenue Per Share (ttm)2.65
Quarterly Revenue Growth (yoy)-1.00%
Gross Profit (ttm)N/A
EBITDA 9.49M
Net Income Avi to Common (ttm)-3.42M
Diluted EPS (ttm)-0.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.28M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)42.77M
Total Debt/Equity (mrq)58.53%
Current Ratio (mrq)1.85
Book Value Per Share (mrq)1.68

Cash Flow Statement

Operating Cash Flow (ttm)14.03M
Levered Free Cash Flow (ttm)13.11M